Single-dose intravenous administration of recombinant human erythropoietin is a promising treatment for patients with acute myocardial infarction - randomized controlled pilot trial of EPO/AMI-1 study -. (Q53293406)
Jump to navigation
Jump to search
scientific article published on 22 May 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Single-dose intravenous administration of recombinant human erythropoietin is a promising treatment for patients with acute myocardial infarction - randomized controlled pilot trial of EPO/AMI-1 study -. |
scientific article published on 22 May 2010 |
Statements
Single-dose intravenous administration of recombinant human erythropoietin is a promising treatment for patients with acute myocardial infarction - randomized controlled pilot trial of EPO/AMI-1 study -. (English)
1 reference
Takuya Ozawa
1 reference
Ken Toba
1 reference
Hiroshi Suzuki
1 reference
Kiminori Kato
1 reference
Yoshitaka Iso
1 reference
Yasushi Akutsu
1 reference
Youichi Kobayashi
1 reference
Youichi Takeyama
1 reference
Naohiko Kobayashi
1 reference
Norihiko Yoshimura
1 reference
Kohei Akazawa
1 reference
Yoshifusa Aizawa
1 reference
EPO/AMI-I Pilot Study Researchers
1 reference
22 May 2010
1 reference
74
1 reference
7
1 reference
1415-1423
1 reference
Identifiers
1 reference